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ABSTRACT: 
 
PURPOSE: Osteoporosis is a multi-factorial, age-related disease with a complex 
etiology and mode of regulation involving a large numbers of genes. To better 
understand the possible relationships among genes, we fingerprinted genes in a rat 
model induced by ovariectomy to determine differences among osteoporotic, non-
osteoporotic, aged and juvenile rats.         
METHODS: We applied genome wide cDNA microarray technology to analyze genes 
expressed in bone marrow mesenchymal stromal cells (BMSC) and compared non-
osteoporotic adult vs osteoporotic, non-osteoporotic adult vs aged, and non-
osteoporotic adult vs juvenile. Rigorous statistical analysis of functional annotation 
(EASE program) identified over-represented biological and molecular functions with 
significant group wide changes (p≤0.05). Some of the expressed genes were further 
confirmed by quantitative RT-PCR (reverse transcription-polymerase chain reaction)  
RESULTS: Differences in gene expression were observed by identifying transcripts 
selected by t-test that were consistently changed by a minimum of two-fold. There 
were 195 transcripts that showed an increased expression and 109 transcripts that 
showed decreased expression relative to the osteoporotic condition. Of these, 75% 
transcripts were unknown gene products or ESTs (expressed sequence tag). A number 
of genes found in the aged and juvenile groups were not present in the osteoporotic 
rats. Functional clustering of the genes using the EASE bioinformatics program 
revealed that transcripts in osteoporosis were associated with signal transduction, lipid 
metabolism, protein metabolism, ionic and protein transport, neuropeptide and G-
protein signaling pathways.  Although some of the genes have previously been shown 
to play a key role in osteoporosis, several genes were uniquely identified in this study 
and likely play a role in developing aged related osteoporosis that could have 
compelling implications in the development of new diagnostic strategies and 
therapeutics for osteoporosis.    
CONCLUSIONS: These data suggest that osteoporosis is associated with changes of 
multiple novel gene expression and that numerous pathways could play important 
roles in osteoporosis pathogenesis. 
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INTRODUCTION: 
Aging of the human skeleton is characterized by decreased bone formation and bone 
mass. These changes are more pronounced in patients with osteoporosis. Osteoporosis 
is a silent epidemic, characterized by low bone density, leading to low trauma 
fractures (i.e., fragility fractures) among the elderly [1-3]. Fragility is due to intrinsic 
skeletal factors such as low bone mass, diminished cancellous bone, trabecular 
fenestrations and an imbalance in bone formation and resorption [4-6].  
Osteoporosis is a complex disease with multifactorial determinants that include life 
style and hormonal influences as well as genetics. Estrogen plays a fundamental 
role in skeletal turnover and bone homeostasis. Many animal studies on 
osteoporosis are using ovariectomy to represent an optimal osteoporotic model to 
investigate the effects of estrogen deficiency. It has been noted that osteoporosis and 
its associated phenotypes are under strong genetic control [7-10]. Identification and 
characterization of either specific loci or genes involved in determining osteoporosis 
will contribute to a greater understanding of the pathogenesis of osteoporosis and 
could lead to the development of innovative diagnostic and treatment strategies.  
Consequently, the objective of the study was to use microarray technology to identify 
gene expression differences in BMSC among juvenile, adult, osteoporotic associated 
with estrogen deficiency and aged rats. Adult bone marrow stroma contains a subset 
of non-hematopoietic cells referred to as mesenchymal stem cells (MSC) or 
mesenchymal progenitors. These cells have the capacity to differentiate to osteoblasts. 
The osteoporotic condition involves osteoblast dysfunction. Consequently, since 
MSCs can differentiate into osteoblasts, it is logical to study gene expression in the 
MSC: an osteoblast pre-cursor cell.  
Gene expression and early microarray studies have shown that there are at least 200 
genes directly or indirectly involved in bone metabolism which may contribute to 
either development or prevention of osteoporosis [11]. Recently, the first in vivo 
microarray study directly measuring osteoporosis in human circulating monocytes 
was reported by Liu et al. [12]. Further studies using microarrays described gene 
expression in the human osteoclast differentiation [13-16]. Therefore, we decided that 
microarray techniques would be suitable to study gene expression in osteoblast pre-
cursor cells (i.e., MSCs) to determine if different gene expression patterns occurred 
among non-osteoporotic, osteoporotic, geriatric and juvenile rats.  
 
 
MATERIALS AND METHODS: 
Experimental design, tissue culture and RNA isolation: 
The study was approved by the Institutional Animal Care and Use Committees 
(IACUC) at the University of Pittsburgh and Carnegie Mellon University and 
complies with the Animal Care and Use Guidelines of the NIH. The surgical facilities 
at the University of Pittsburgh where surgeries were performed are AAALAC 
approved (American Association for Accreditation of Laboratory Animal Care). 
Briefly, four types of physiological conditions were emphasized in female Lewis rats.  
These included:  geriatric rats (more than two years old), osteoporotic rats (seven 
months old), non-osteoporotic adult rats (seven months old) and juvenile rats (seven 
weeks old). Each group contained three animals for individual BMSC isolation 
and subsequent microarray studies. There were three microarray data generated 
for each group. The RNA samples left from microarray study were used for real 
time PCR to confirm microarray result. Thus, each group generated three set of 
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data for statistics. The fold of changes of interested gene expression was 
presented by mean value. 
Osteoporosis was induced by ovariectomy of three-month old rats, followed by a 30% 
caloric reduced diet and four months to develop osteopenia [5, 17]. Histological 
validation of these animal models demonstrated significant loss of bone density in the 
rats’ tibiae and femurs (Figure 1), with typical fenestrated trabeculae.    
Isolation and culture of rat BMSCs  
Three bone marrow samples from each group of rats were isolated by flushing the 
femurs with 10 ml mesenchymal stem cell culture media (HyClone, Logan, UT), 
supplemented with 10% fetal bovine serum (HyClone, Logan, UT), 100 U/ml 
penicillin/100 µg/ml streptomycin, 2 mM glutamine. Clumps of bone marrow were 
gently minced with a pipette. Cells were centrifuged for 10 min at 1000 rpm, washed 
by the addition of fresh medium, centrifuged again, re-suspended and plated out in the 
same stem cell culture media mentioned above at a density of ~2x106 cells/cm2 in 25 
cm2 plastic culture dishes. The cells were incubated at 37°C in 5% CO2.  
Non-adherent cells were removed by replacing the medium after 7 days. Cells were 
grown for a further seven days to confluency, then washed with phosphate-buffered 
saline (PBS) and lifted by incubation with 0.25% trypsin/2 mM EDTA for 5 min. 
Non-detached cells were discarded and the remaining cells were regarded as 
passage 1 of the BMSC culture and further cultured for seven days before RNA 
extraction. In our previous study we have demonstrated that all adherent cells do 
not express haematopoietic markers such as CD34 and CD45, and are positive 
for CD29, CD 73, CD90, CD105 and CD166 (data not shown). 
RNA isolation 
Total RNA was isolated using TRIZOL Reagent (Invitrogen, CA, USA). Assessment 
of the concentration and quality of the total RNA samples were carried out by 
spectrophotometry and Agilent Bioanalyzer. 
Microarray procedure: 
CodeLink Rat Whole Genome Bioarrays (GE HealthCare, Piscataway, NJ, USA) 
were used for this study.  Biotin-labeled cRNA target was prepared by linear 
amplification methods as described in CodeLink Protocols. The poly (A) + RNA 
subpopulation (within the total RNA population) was primed for reverse transcription 
by a DNA oligonucleotide containing the T7 RNA polymerase promoter 5’ to a d (T) 
24 sequences. After second-strand cDNA synthesis, the cDNA served as the template 
for an in vitro transcription (IVT) reaction to produce the target cRNA. The IVT was 
performed in the presence of biotinylated nucleotides to label the target cRNA. This 
method produced approximately 1000-fold to 5000-fold linear amplification of the 
input poly (A) + RNA.   
To monitor each key step, a set of bacterial control mRNAs was included in the 
cDNA synthesis and the IVT reactions.  In addition, these bacterial control mRNAs 
were used to estimate the sensitivity of RNA detection. An aliquot of the labeled 
cRNA was run on Agilent’s Bioanalyzer for qualification and quantization. Only high 
quality cRNA with yield of more than 10 μg were fragmented and hybridized to 
CodeLink Bioarrays. Hybridization was performed overnight in a temperature-
controlled incubator shaker. Most of the labeling and hybridization reagents were 
included in GE CodeLink Expression Assay Reagent Kit. 
Post hybridization processing 
Post-hybridization processing included a stringent wash to remove unbound and non-
specifically hybridized target molecules, a staining step with CyTM5-Streptavidin 
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conjugate, and several non-stringent washing steps to remove unbound conjugate. 
Following a final rinse, the Bioarrays were spun dry and ready to be scanned. 
Image and data analysis: 
All CodeLink Bioarrays were scanned using ScanArray 5000 (PerkinElmer, 
Wellesley, MA, USA).  Scan images were analyzed using CodeLink Expression 
software to generate raw data.  Raw data were imported into GeneSpring software 7.2 
(Agilent, Palo Alto, CA, USA).  Log transform of raw data were normalized to: first, 
the median intensity per chip; and second, the median intensity per gene.  T-tests were 
performed on normalized data to identify differentially expressed genes between 
different treatment groups (p≤0.05).  These genes were filtered by fold change and 
only genes with at least a two-fold change between treatment groups were selected for 
further analysis.  
 
Quantitative RT-PCR confirmation: 
According to the representative expression from microarray data among four 
different physiological groups, nine genes were selected for quantitative RT-PCR 
confirmations of the hybridized results. Total RNA was isolated using Trizol reagent 
as described above.  After treatment with DNase I to eliminate possible contamination 
of genomic DNA, RNA was quantified using RiboGreen fluorescent dye (Molecular 
Probes, Inc. Eugene, OR). Quantitative real-time RT-PCR (q-RT-PCR) was 
performed using TaqMan Reverse Transcription Reagents and SYBR Green PCR 
Master Mix (Applied Biosystems Foster City, CA) in an ABI Prism 7000 sequence 
detection system. In brief, 30-50 ng of total RNA, 6 units of TaqMan reverse 
transcriptase, 25 pmole of gene specific primers and 12.5 μl of 2x Master Mix were 
used in a 25 μl reaction volume. Quantitative RT-PCR reactions were set up in 
triplicates. The thermocycling conditions were as follows: 1 cycle of 30 minutes at 48 
ºC for reverse transcription, 1 cycle of 10 minutes at 95 ºC for activation of the 
polymerase, 40 cycles of 15s at 95 ºC and 1 minute at 60 ºC for amplification. After 
the final cycle of the amplification, the dissociation curve analysis was carried out to 
verify that no primer dimer and/or non-specific amplified products were produced. 
The primer sequences of the testing genes were listed in table 1. The housekeeping 
gene glyceraldehydes-3-phosphate-dehydrogenase (GAPDH) was used as an 
endogenous reference gene to normalize the calculation by Comparative Ct (Cycle of 
threshold) value method  [18]. The ∆CT value was obtained by subtracting the 
GAPDH Ct value from the test gene Ct value of the same samples. The ∆∆CT was 
determined by subtracting the ∆CT of target sample from the ∆CT of the control 
sample. The relative mRNA quantification of the target gene was given by 2-∆∆ CT. 
Analysis of functional clustering and over representation  of differentially 
expressed genes. 
Bioinformatics (EASE program, see http://apps1.niaid.nih.gov/david) and literature 
analyses were performed to identify functional implications of differentially 
expressed genes by 2 fold. For the experiments described here, we used only the 
“biological process” and “Molecular function” Ontologies. Gene ontology classes 
with fewer than four or more than 30 genes represented in the data were not 
considered.  
 
RESULTS: 
Overview of differentially expressed genes 
A total of 34,000 genes were spotted on CodeLink Rat Whole Genome Bioarrays, of 
which 29,000 were well-substantiated rat genes. Differences in gene expression were 
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observed by identifying transcripts selected by t-test that were consistently changed 
by a minimum of two-fold. A balanced differential expression of 2 fold or higher has 
been shown previously to be significant [19-21].  Of the identified genes among 
osteoporotic vs seven-month old non-osteoporotic, 195 transcripts showed increased 
expression and 109 transcripts showed decreased expression, with 75% transcripts 
being ESTs or unknown gene products.  
Of the seven-month old non-osteoporotic vs aged rats, 62 genes were up-regulated 
and 86 genes were down-regulated. The remaining 86% genes that differentially 
expressed were either unknown or ESTs. In addition, there were 120 genes up-
regulated and 80 genes down-regulated in the comparison between the juvenile rat 
and the seven-month old non-osteoporotic.  
A list of differentially expressed genes in osteoporosis, assigned with the gene name 
and symbol are shown in Table 2. 
Functional gene grouping: 
Using the Gene Ontology (GO) tool EASE [22], we grouped the transcripts based on 
the Biological process and Molecular function. This tool is useful to determine the 
over-represented categories in the list of differentially expressed genes. Because of 
the small number of down-regulated genes identified by gene spring in osteoporosis, 
statistical analysis for significance of GO group changes with this gene list was 
considered not valid.  
The individual annotation of the genes suggested most of the genes that were down-
regulated were involved in hormone activity, for example neuropeptide y (Npy), 
prolactin like protein C, prolactin like protein B and cell growth and maintenance, 
such as  Npy, Ramp3, Kcnk1, MlP and RIM 2. 
The main gene groups over-represented in the comparison between seven-month old 
non-osteoporotic vs the osteoporotic involved genes associated with signal 
transduction, protein and lipid metabolism, G-protein and neuropeptide signaling 
pathways.  
When comparing up-regulated genes among aged vs. seven-month old non-
osteoporotic, the predominant gene groups included apoptosis, G-protein coupled 
receptor protein signaling pathway, cell growth and maintains and transport. Where as 
catabolism (protein and macromolecule), protein and peptidolysis and immune 
response were predominant over represented groups among the down-regulated genes 
between aged vs seven month old non-osteoporotic. Furthermore, relatively large 
gene group changes were observed between juvenile vs. seven-month old non-
osteoporotic, compared to other age groups. These differences included biosynthesis, 
cell proliferation, organogenesis, metabolism (nucleobase, nucleotide, nucleic acid 
metabolism, phosphate, carboxylic acid, and lipid metabolisms), ion transport, 
macromolecule catabolism, immune response and signaling pathways.  
In terms of the molecular function, oxido reductase activity, structural molecule 
activity, metal ion binding, and catalytic activities were over-represented in up-
regulated osteoporotic rat vs non-osteoporotic gene expression profiles of BMSCs. 
However, most of the up-regulated genes among aged vs seven month old non-
osteoporotic were involved in the signal transducer activity, receptor activity 
(rhodopsin and G-protein coupled and transmembrane). Moreover, the endopeptidase 
activity, calcium ion binding and kinase activity were over represented groups among 
the down regulated genes between aged vs seven month non-osteoporotic. Overall, 
juvenile vs seven months old non-osteoporotic gene expression profiles were enriched 
with categories like hormone activity, cell adhesion molecule activity and receptor 
activity.  
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Gene classification of non-osteoporotic adult vs osteoporotic 
The genes were grouped according to development, metabolism, catabolism, 
transport, biosynthesis, apoptosis, cell growth and differentiation. 
Skeletal development: 
The genes Slit3, Nog, Comp are structural constituents important for skeletal 
development. Up-regulation of these genes was determined in the juvenile and 
osteoporosis groups and was down-regulated in the aged group. The genes like 
Tnnt2,  Csrp2 and Lama3 Which are important for the muscle development 
were upregulated in osteoporosis profile. Similarly, the genes Alpl and Zic1 
important for collagen synthesis, were greater in the osteoporotic vs the adult 
seven-month old non-osteoporotic.  
Metabolism: 
This group includes diverse metabolisms like protein, lipid, carboxylic acid, organic 
acid, nucleoside, nucleotide and nucleic acid metabolisms and bone mineral 
metabolism. All these processes are essential for tissue regeneration and bone mineral 
density (BMD) maintenance. They are also important for synthesis of structural 
constituents, and many of these genes are important for osteoclast and osteoblast 
activity. Genes encoding metabolisms especially protein, lipid, carboxylic and 
nucleobase/nucleoside/nucleotide were the largest group of genes regulated in the 
osteoporosis compared to normal. Our study showed that genes in the above group 
were up regulated in the osteoporosis and were predominant during osteoporotic state. 
Functionally, these processes are essential for tissue regeneration and BMD 
maintenance (Alpl). They are also important for synthesis of structural constituents 
(Uchl1), and many of these genes are important for osteoclast and osteoblast activity 
(Crabp2, Mmp8).  
Signaling Pathways: 
Among the signal transduction related genes affected by the osteoporosis included 
mainly G-protein coupled receptor protein signaling pathway (Hcrtr1, Htr2b, Ucn, 
Trrp6, Cirl3) and neuropeptide signaling pathways (Hcrtr1, Ucn, Cirl3). Both of these 
pathways were up regulated in osteoporosis which implies that these pathways are 
likely to interfere in diseased state.  
Transcription:  
Despite the fact that transcription factors were generally weakly expressed, we 
detected three regulated transcription factor genes with reliable hybridization signals. 
These are functionally important for osteoblast activity (Crabp2). Furthermore we 
confirmed regulation patterns for one of these genes by real-time RT-PCR (Crabp2). 
The regulation of a number of transcription factors suggested that poorly orchestrated 
regulation with a very low number of genes were playing crucial role in developing 
disease pathogenesis.  
Cell growth and maintenance:  
One of the striking findings in our study was the regulation of large number of genes 
encoding for cell growth and maintains. G-protein and neuropeptides were up-
regulated in the osteoporotic and aged rat gene profiles and were down-regulated in 
the juvenile.  The transcriptional process genes were up-regulated in both osteoporotic 
and juvenile rats and were down-regulated in the aged. Moreover a number of genes 
present in this category are important for osteoblasts (Crabp2, ALPL) and osteoclast 
activity (Csrp2) as well as for maintaining BMD (Cdkn2b). The up regulation of these 
genes in osteoporosis was identified. 
Hormone activity:  
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Among the down-regulated annotated transcripts the important phenomena we 
observed was the decreased expression of hormones like Npy, Prlpb, Plpc-b. It was 
noted that the imbalance in hormone activity was directly related to osteoporosis.        
Biosynthesis and apoptosis:  
Apoptosis related genes were highly up-regulated in the aged profile compared to the 
osteoporotic and juvenile groups.  
 
Quantitative RT-PCR 
Selected marker genes were validated by real time RT-PCR. Some slight variations 
were detected in the expression of selected genes between microarray and quantitative 
PCR methods. In general, there was a correlation between the real time PCR analysis 
and microarray results, thus validating the microarray results (Figure 2).  
 
DISCUSSION 
We have compared the relative expression levels of more than half of the genes 
predicted to comprise the rat genome in osteoporotic, normal, juvenile, and aged 
cohorts. We confirmed the validity of the dataset by quantitative RT-PCR and 
clustered the differentially expressed genes into the functional categories.  
Our emphasis was primarily on genes involved in estrogen related osteoporosis. 
Consequently, we will focus our discussion on osteoporotic profiles in comparison 
with the juvenile, non-osteoporotic and aged groups.  
The microarray analysis identified over 308 genes that were altered in the non-
osteoporotic (seven-month old rat) compared to osteoporotic rats. There were 195 
genes that were increased and 109 genes that decreased more than 2 folds between the 
non-osteoporotic and osteoporotic. Ease analysis was used to correlate genes and 
groups of genes with GO biological processes, which were further analyzed and 
cross-referenced with the literature. Furthermore the osteoporotic genes we identified 
may include novel candidate biomarkers for pathogenesis of osteoporosis.  
Data indicated multiple novel differences in gene expression among the designated 
study populations of osteoporotic and non-osteoporotic seven-month old, aged (> two 
years) and juvenile groups. Although descriptions of all the individual genes that 
exhibited altered expression were too cumbersome to report, many of the detected 
gene expression differences involved ESTs with no known function. All the 
comparison results including osteoporotic vs adult non-osteoporotic and adult 
non-osteoporotic vs aged were listed in table 2. 
 
The majority of genes whose expression levels were altered in osteoporosis exhibited 
an increased pattern. These genes function in diverse processes, including signal 
transduction, protein metabolism, cell growth or maintenance, lipid metabolism, 
structural component synthesis and G-Protein. Many of these processes represent 
metabolic systems designed to maintain bone homeostasis and tissue turnover and 
their increased expression represents compensation for stresses related to bone loss 
and bone formation. Some examples of individual genes are lipo protein lipase, which 
plays a role in adipogenic differentiation in the bone marrow stroma [23] and cellular 
retinoic acid binding protein 2 (Crabp-2). Crabp2 is presumed to modulate the level of 
retinoic acid available to bind to the receptor in cells. Expression of Crabp-2 has been 
observed in osteoblasts [24]. G-protein coupled receptor activation is vital to the 
functional viability of both osteoblasts and osteoclasts, which in part involves in the 
successful communication between cell types [25, 26]. Moreover, the presence of 
nerve fibers in skeletal tissue and presence of receptors for several neurotransmitters 
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on both osteoblasts and osteoclasts have suggested a possible role for neuropeptides in 
the regulation of skeletal metabolism [27].  
Another gene we identified was ALOX. A study reported that over-expression of 
ALOX gene kept mice from reaching peak bone mass [28].  We also found up-
regulation of matrix metallo proteins 8. This factor is involved in osteoblast 
differentiation and mineralization [29]. Further, cytochrome p450 hormonal function 
and its dysfunction will lead to osteoporosis [8].   
Fewer genes exhibited decreased expression in osteoporosis. Because of the relatively 
small number of down-regulated genes, over-representation analysis is unlikely to be 
informative. It could be either too specific or too general [30]. The logic for this 
statement is that the annotated down-regulated genes function in bone anabolism, and 
their decreased expression may reflect a possible cause for either decreased bone mass 
or osteoblast activity.    
There were several genes identified in the osteoporotic rats that had a decrease in 
expression. These genes were: Calcitonin, a peptide hormone, involved in calcium 
homeostasis through their actions on osteoblast and osteoclast [31]; Wingless-type 
MMTV integration site family member 4, which plays a role in osteoblast and 
adipocytes differentiation and function [32]; Neuropeptide Y, that controls bone 
growth [33]; and calmodium, which influences osteoblast ion transport, growth and 
differentiation [34]. Additional down-regulated genes in the osteoporotic rat included: 
Interleukin 1 receptor, associated with osteoclast and osteoblast metabolism [34];  F-
spondin2, which promotes nerve precursor differentiation [35]; and prolactin like 
protein c gene, reported to have an inhibitory effect on osteoblast formation. [36].   
Some of the genes were uniquely identified between aged and adult non-osteoporotic 
groups. Relatively broad arrays of genes were down-regulated in the aged group 
compared to up-regulated genes. Among the down-regulated genes, the predominant 
functional processes include oxido-reductase activity, endopeptidase activity, metal 
ion binding, structural molecule synthesis and metabolism. There was no 
overlapping gene identified in the known up-regulated or down regulated genes 
both in aged and osteoporotic rats in comparison with adult non-osteoporotic 
rats. Interestingly we noted 14 genes that were up regulated in osteoporosis but 
down regulated in aged and six genes that were down regulated in osteoporosis 
but up regulated in aged. As the aged rats were not osteoporotic in our animal 
model, these differential expression genes in osteoporotic and aged rats may 
indicate a more relevant role in the development of osteoporosis. Among 14 
genes that were up regulated in osteoporotic and down in aged rats were MMP8, 
Sponf1, Csrp2, Ivl, Fol r1, Crabp2, Loc64305, Nac-1, Gludins, Braf, InhBp, Pgr, 
Slc26a1, and sulphate Sp. The six genes which were down regulated in 
osteoporotic but up regulated in aged were Prlpb, Ii1rn, PlpcB, Loc171569, 
Ramp3, Mip.  
 
There were specific genes down-regulated in the aged groups that included insulin 
like growth factor binding protein 3 and 6 (IGFBP3 and IGFBP6),, which regulate 
osteoclastogenesis. Previous studies [8] reported that the decreased expression of 
IGFs predisposes to osteoporosis. However, IGF-1 was not significantly changed in 
comparing osteoporotic vs non osteoporotic in our microarray data. Further, 
tumor necrosis factor receptor superfamily member 6 was decreased and is important 
for bone remodeling and repair. Moreover, interleukin 6 signal transducer, another 
down-regulated gene, is noteworthy for osteoprogenitor differentiation and bone 
formation.     
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The majority of the up-regulated genes contrasting the aged and adult non-
osteoporotic groups emphasized cell growth and differentiation, transcription, and 
apoptosis related gene categories. These genes are related to the processes for tissue 
turnover and decrease during bone anabolism. Some examples of genes up-regulating 
in the aged profile were  Kruppel-like factor 5, which is important for osteoblast 
differentiation and maturation [34] ; Apo E  receptor -2,  which facilitates the 
intravascular transport of blood lipids [37, 38]; and Vitamin K [39-41],  interleukin 8 
receptor beta and interleukin 9, which modulate bone homeostasis. Overall, the 
juvenile expression profile had an over-representation of growth and differentiation 
related genes important for building bone mineral density. Through our experiments 
we demonstrated that age is not only the factor triggering osteoporosis, genetic 
factors play a predominant role in onset of the disease.    
 
Conclusions: Some global changes of gene expression were reported that were 
associated with age (> two year old rats vs juvenile rats), as well as osteoporosis vs 
normal adult (seven month old rats), non-osteoporotic.  Several gene expression 
patterns emerged and several protein correlations were determined.  
This report is the first we know of that uses a gene microarray profile and RT-PCR to 
correlate gene expression in different physiological population cohorts in the rat. The 
outcome underscores the opportunity to pursue more comprehensive and far-reaching 
studies to determine relationships between the gene-protein expression levels and the 
physiological conditions.  
Especially compelling is the opportunity to use the techniques described to identify 
patterns of gene expression in the juvenile and non-osteoporotic adult that may predict 
the susceptibility to the osteoporotic condition, and further, to use that information to 
design and develop therapeutic intervention to preclude osteoporosis from occurring 
in the susceptible individual. However, further confirmation at the protein level and 
functional analysis will be necessary.                                    
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LEGENDS: 
Figure 1: Histological validation of animal models. Significant loss of bone density 
in tibia and femur was noted in osteoporotic rats with typical fenestrated trabeculae. 
All pictures were taken at 40 times magnification from growth plate in epiphysis 
part of tibia and epiphyseal disk of femur head. 
 
Figure 2: Validation of selected gene expression quantified by microarray and real 
time PCR. Three animals from each different physiological group were analyzed 
in triplicate by real-time PCR. The unit of Y-axis in each graph is the expression 
level measured in mocroarray and Q-PCR Abbreviations: Igfbp3 (insulin like 
growth factor binding protein 3); C4a (complement component 4a); Spp1 
(secreted phosphoprotein 1); Ctsc (cathepsin C); Lpl (lipoprotein lipase); Cyr61 
(cysteine rich protein 61); Crabp2 (cellular retinoic acid binding protein 2), 
Lgals (lectin, galactose binding, soluble); Pspla1 (phosphatidylserine-specific 
phospholipase A1) 
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Table 1: Primer sequences for real-time PCR 
 
 
 
 
 
 
 
Sequence Name Sequence forward Sequence reverse 
Rat Lpl  GACAATGTCCACCTCTTAG CGAAATCCGCATCATCAG 
Rat Crabp2  GAGACCCTGTAAGAGTTTG ACAACGTCGTCTGCTGTCAT 
Rat Ogc  GGAGCGCATGGAAGAGAT GGTGAGCATTCAGTCAGAG 
Rat Loc GACATTCAGCCAGGACTTC GTGTTGTCTGTCCACTTC 
Rat Npy  CTGCGACACTACATCAATCTC GGAAAAGTCAGGAGAGCAAG 
Rat Lgals9  CAGCACCCAGCCTCCATAC GCAATGTCATTTCCACTGAAG 
Rat Pspla1  CCTCAAAGTCCAGTTTCTC GTTCCTAATGCCCTGAATC 
Rat Igfbp3  CTGAAGGCGCTGCTGAATG GAATGGAGTGGATGGAACTTG 
Rat C4a  CACGGTCACAGTGGAG CTCGAGGCCATCTGAGAAC 
Rat Spp1  GGTTTGCCTTTGCCTGTTC CGTTTCTTCAGAGGACACAG 
Rat Ctsc  GGTAATGGAACCAACAGAAG CTGCCTTTGACTTCATACTTG 
Rat Hpse  CTCCTCAACTACTGCTCTTC CCAATGTCAGGACCATAGAG 
Rat Cyr61  CAGTTCCACCGCTCTGAAAG CCCACAGCACCGTCAATAC 
Rat GAPDH GTCGGTGTGAACGGATTTG GAACATGTAGACCATGTAGTTG 
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Table 2: A list of differentially expressed genes in osteoporosis 
 
 
UP REGULATED GENES: OSTEOPOROSIS vs NORMAL 
 
Accession number Fold Change Gene name Gene symbol 
NM_172067 7.206500715 f-spondin 1  Sponf1 
NM_017244 5.925456922 cellular retinoic acid binding protein 2  Crabp2 
NM_012488 5.58071026 alpha-2-macroglobulin  A2m 
NM_017300 5.232851118 bile acid-Coenzyme A: amino acid N-acyltransferase  Baat 
NM_012676 4.873456913 troponin T2  Tnnt2 
NM_022195 4.302501416 involucrin gene , mRNA IvI 
NM_138547 4.280290075 3-alpha-hydroxysteroid dehydrogenase  LOC191574 
XM_342661 3.986285988 similar to RIKEN cDNA B130055L09  LOC362341 
NM_019150 3.902632624 urocortin  Ucn 
NM_019234 3.823798707 dynein, cytoplasmic, intermediate chain 1  Dncic1 
NM_022513 3.44841335 dopa/tyrosine sulfotransferase  (LOC64305) 
NM_021585 3.318636041 surface protein MCA-32  Mca32 
NM_022221 3.284426686 neutrophil collagenease  Mmp8 
M92916 3.86281E+13 glucose-dependent insulinotropic peptide mRNA exons 1-5  
NM_031732 3.2823E+13 sulfotransferase family 1A, member 2  Sult1a2 
NM_147206 3.041065227 cytochrome P450 3A9  Cyp3a9 
RAFB 2.986459081 transient receptor protein 6  Trrp6 
NM_175766 2.942583035 calcium-independent alpha-latrotoxin receptor homolog 3  Cirl3 
CB765685 2.934456722 cytochrome P450 monooxygenase Cyp2J3 
NM_032056 2.676779303 NAC-1 protein  (Nac-1) 
BQ202830 2.662309904 transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) Tap2 
AI406334 2.607565472 alpha 2 integrin  
CB780602 2.563877392 transmembrane 4 superfamily member 4  Tm4sf4 
AW524553 2.530026522 progesterone receptor  Pgr 
CF111358 2.518558099 5-hydroxytryptamine (serotonin) receptor 2B  Htr2b 
BF397285 2.394665348 alkaline phosphatase, tissue-nonspecific  Alpl 
H34885 2.378235274 retinal pigment epithelium, 65 kDa  Rpe65 
AF217593 2.318932107 camello-like 1  Cml1 
AA891834 2.289758835 hypocretin receptor 1  Hcrt1 
NM_130812 2.245097788  (Solute carrier family 25, member 13) (Citrin)  LOC362322 
AI579087 2.242869821 cyclin dependent kinase inhibitor 2B  Cdkn2b 
BQ205131 2.221184775 uterine sensitization-associated gene 1 protein  Usag1 
BF394474 2.212824744 BMP/retinoic acid-inducible neural-specific protein 3  (Brinp3) 
CK356986 2.86405E+12 zic protein member 1  Zic1 
NM_031641 2.78896E+13 similar to sulfatase FP  LOC311642 
BI288264 2.72533E+13 sulfotransferase family 4A, member 1  Sult4a1 
BM388060 2.40131E+13 similar to stem cell adaptor protein STAP-1  (LOC305269) 
CB731861 2.32216E+13 solute carrier family 26 (sulfate transporter), member 1  Slc26a1 
AB046449 2.17217E+13 similar to kaiso protein; zinc finger transcription factor   (LOC315936) 
BF419434 2.14942E+12 putative bHLH transcription factor  
BG666688 2.066735546 arachidonate 5-lipoxygenase  Alox5 
NM_173306 2.05855647 inhibin binding protein  Inhbp 
AA819179 2.057360408 laminin 5 alpha 3  Lama3 
CK470759 2.049397622 enoyl-Coenzyme A,  Ehhadh 
NM_031114 2.030111871 protein phospatase 3, regulatory subunit B, alpha isoform  Ppp3r2 
BQ193682 2.029116572 S-100 related protein, clone 42C  S100a10 
BM385409 2.025136744 cysteine rich protein 2  Csrp2) 
NM_031242 2.014123401 ubiquitin carboxy-terminal hydrolase L1  Uchl1 
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NM_031242 2.008129129 CDP-diacylglycerol synthase  1  Cds1 
 
INDIVIDUAL FUNCTIONALLY CLUSTERED GENES: 
INCREASED IN OSTEOPOROSIS: 
BIOLOGICAL PROCESS 
1. Response to external stimulus 
NM_012488 alpha-2-macroglobulin A2m 
NM_012822 arachidonate 5-lipoxygenase Alox5 
NM_017237 ubiquitin carboxy-terminal hydrolase L1 Uchl1 
NM_017300 bile acid-Coenzyme A: amino acid N-acyltransferase Baat 
NM_019150 urocortin Ucn 
NM_032056 transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) Tap2 
NM_053562 retinal pigment epithelium, 65 kDa Rpe65 
NM_147206 cytochrome P450 3A9 CYP3A9 
 
2. Cell communication: 
NM_013064 hypocretin receptor 1 Hcrtr1 
NM_017244 cellular retinoic acid binding protein 2 Crabp2 
NM_017250 5-hydroxytryptamine (serotonin) receptor 2B Htr2b 
NM_019150 urocortin Ucn 
NM_031114 S-100 related protein, clone 42C S100a10 
NM_053559 transient receptor protein 6 Trrp6 
NM_130822 calcium-independent alpha-latrotoxin receptor homolog 3 Cirl3 
NM_172067 f-spondin Sponf 
 
3. Cell growth and Maintenance 
NM_012488 alpha-2-macroglobulin A2m 
NM_013059 alkaline phosphatase, tissue-nonspecific Alpl 
NM_017244 cellular retinoic acid binding protein 2 Crabp2 
NM_019234 dynein, cytoplasmic, intermediate chain 1 Dncic1 
NM_022287 solute carrier family 26 (sulfate transporter), member 1 Slc26a1 
NM_032056 transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) Tap2 
NM_053559 transient receptor protein 6 Trrp6 
NM_130812 cyclin dependent kinase inhibitor 2B Cdkn2b 
NM_133527 folate receptor 1 (adult) Folr1 
NM_133606 enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase Ehhadh 
NM_177425 cysteine rich protein 2 Csrp2 
 
4. Signal transduction 
NM_013064 hypocretin receptor 1 Hcrtr1 
NM_017244 cellular retinoic acid binding protein 2 Crabp2 
NM_017250 5-hydroxytryptamine (serotonin) receptor 2B Htr2b 
NM_019150 urocortin Ucn 
NM_031114 S-100 related protein, clone 42C S100a10 
NM_053559 transient receptor protein 6 Trrp6 
NM_130822 calcium-independent alpha-latrotoxin receptor homolog 3 Cirl3 
 
5. Organogenesis 
NM_012676 troponin T2 Tnnt2 
NM_013059 alkaline phosphatase, tissue-nonspecific Alpl 
NM_017244 cellular retinoic acid binding protein 2 Crabp2 
NM_017250 5-hydroxytryptamine (serotonin) receptor 2B Htr2b 
NM_022677 zic protein member 1 Zic1 
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NM_173306 laminin 5 alpha 3 Lama3 
NM_177425 cysteine rich protein 2 Csrp2 
 
6. Metabolism 
A.Protein metabolism 
NM_013059 alkaline phosphatase, tissue-nonspecific Alpl 
NM_017237 ubiquitin carboxy-terminal hydrolase L1 Uchl1 
NM_022221 neutrophil collagenease Mmp8 
NM_053785 transmembrane 4 superfamily member 4 Tm4sf4 
NM_133527 folate receptor 1 (adult) Folr1 
 
B. Lipid metabolism 
NM_012822 arachidonate 5-lipoxygenase Alox5 
NM_017300 bile acid-Coenzyme A: amino acid N-acyltransferase Baat 
NM_031641 sulfotransferase family 4A, member 1 Sult4a1 
NM_133606 enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase Ehhadh 
NM_138547 3-alpha-hydroxysteroid dehydrogenase LOC191574 
 
C. Carboxylic acid metabolism 
NM_012822 arachidonate 5-lipoxygenase Alox5 
NM_017300 bile acid-Coenzyme A: amino acid N-acyltransferase Baat 
NM_133606 enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase Ehhadh 
 
D. Organic acid metabolism 
NM_012822 arachidonate 5-lipoxygenase Alox5 
NM_017300 bile acid-Coenzyme A: amino acid N-acyltransferase Baat 
NM_133606 enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase Ehhadh 
 
E. Nucleobase\ nucleoside\ nucleotide and nucleic acid metabolism 
NM_017244 cellular retinoic acid binding protein 2 Crabp2 
NM_022847 progesterone receptor Pgr 
NM_134413 NAC-1 protein Nac-1 
      
7. Transcription 
NM_017244 cellular retinoic acid binding protein 2 Crabp2 
NM_022847 progesterone receptor Pgr 
NM_134413 NAC-1 protein Nac-1 
 
8. Neuropeptide signaling pathway 
NM_013064 hypocretin receptor 1 Hcrtr1 
NM_019150 urocortin Ucn 
NM_130822 calcium-independent alpha-latrotoxin receptor homolog 3 Cirl3 
 
9. G-protein coupled receptor protein signaling pathway. 
NM_013064 hypocretin receptor 1 Hcrtr1 
NM_017250 5-hydroxytryptamine (serotonin) receptor 2B Htr2b 
NM_019150 urocortin Ucn 
NM_053559 transient receptor protein 6 Trrp6 
NM_130822 calcium-independent alpha-latrotoxin receptor homolog 3 Cirl3 
 
10. Electron transport 
NM_012822 arachidonate 5-lipoxygenase Alox5 
NM_147206 cytochrome P450 3A9 CYP3A9 
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NM_175766 cytochrome P450 monooxygenase Cyp2J3 
 
11. Hormone activity 
M92916 Glucose-dependent insulinotropic peptide Gludins 
NM_134385 prolactin-like protein C beta Plpcbeta 
 
MOLECULAR FUNCTION 
1. Oxidoreductase activity 
NM_012822 arachidonate 5-lipoxygenase Alox5 
NM_133606 enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase Ehhadh 
NM_138547 3-alpha-hydroxysteroid dehydrogenase LOC191574 
NM_147206 cytochrome P450 3A9 CYP3A9 
NM_175766 cytochrome P450 monooxygenase Cyp2J3 
 
2. Hydrolase activity 
NM_013059 alkaline phosphatase, tissue-nonspecific Alpl 
NM_017237 ubiquitin carboxy-terminal hydrolase L1 Uchl1 
NM_017300 bile acid-Coenzyme A: amino acid N-acyltransferase Baat 
NM_022221 neutrophil collagenease Mmp8 
NM_032056 transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) Tap2 
NM_175763 inhibin binding protein InhBP 
 
3. Structural molecule activity 
NM_012676 troponin T2 Tnnt2 
NM_022195 involucrin gene Ivl 
NM_173306 laminin 5 alpha 3 Lama3 
 
4. Receptor activity 
NM_012488 alpha-2-macroglobulin A2m 
NM_013064 hypocretin receptor 1 Hcrtr1 
NM_017250 5-hydroxytryptamine (serotonin) receptor 2B Htr2b 
NM_022847 progesterone receptor Pgr 
NM_053559 transient receptor protein 6 Trrp6 
NM_130822 calcium-independent alpha-latrotoxin receptor homolog 3 Cirl3 
 
5. Metal ion binding 
NM_012822 arachidonate 5-lipoxygenase Alox5 
NM_013059 alkaline phosphatase, tissue-nonspecific Alpl 
NM_021701 protein phospatase 3, regulatory subunit B, alpha isoform,type 2 Ppp3r2 
NM_022221 neutrophil collagenease Mmp8 
NM_031114 S-100 related protein, clone 42C S100a10 
NM_172067 f-spondin Sponf 
  
6. Catalytic activity 
NM_012822 arachidonate 5-lipoxygenase Alox5 
NM_013059 alkaline phosphatase, tissue-nonspecific Alpl 
NM_017237 ubiquitin carboxy-terminal hydrolase L1 Uchl1 
NM_017300 bile acid-Coenzyme A: amino acid N-acyltransferase Baat 
NM_022221 neutrophil collagenease Mmp8 
NM_022513 dopa/tyrosine sulfotransferase LOC64305 
NM_031641 sulfotransferase family 4A, member 1 Sult4a1 
NM_031732 sulfotransferase family 1A, member 2 Sult1a2 
NM_032056 transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) Tap2 
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NM_053785 transmembrane 4 superfamily member 4 Tm4sf4 
NM_130812 cyclin dependent kinase inhibitor 2B Cdkn2b 
NM_133606 enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase Ehhadh 
NM_138547 3-alpha-hydroxysteroid dehydrogenase LOC191574 
NM_147206 cytochrome P450 3A9 CYP3A9 
NM_175763 inhibin binding protein InhBP 
NM_175766 cytochrome P450 monooxygenase Cyp2J3 
 
7. Binding 
M92916 Glucose-dependent insulinotropic peptide Gludins 
NM_012822 arachidonate 5-lipoxygenase Alox5 
NM_013059 alkaline phosphatase, tissue-nonspecific Alpl 
NM_013064 hypocretin receptor 1 Hcrtr1 
NM_017244 cellular retinoic acid binding protein 2 Crabp2 
NM_019150 urocortin Ucn 
NM_021701 protein phospatase 3, regulatory subunit B, alpha isoform,type 2 Ppp3r2 
NM_022221 neutrophil collagenease Mmp8 
NM_022847 progesterone receptor Pgr 
NM_031114 S-100 related protein, clone 42C S100a10 
NM_032056 transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) Tap2 
NM_130822 calcium-independent alpha-latrotoxin receptor homolog 3 Cirl3 
NM_133527 folate receptor 1 (adult) Folr1 
NM_133606 enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase Ehhadh 
NM_134413 NAC-1 protein Nac-1 
NM_172067 f-spondin Sponf 
NM_177425 cysteine rich protein 2 Csrp2 
 
 
DOWN REGULATED GENES: OSTEOPOROSIS vs. NORMAL 
 
Accession number Fold change Gene name Gene symbol 
M31155 8.968466 prolactin-like protein B mRNA  
NM_012614 4.046593 neuropeptide Y  Npy 
NM_012752 2.987254 CD24 antigen  Cd24 
NM_022194 2.899609 interleukin 1 receptor antagonist gene  II1rn 
XM_237334 2.815044 similar to sphingosine kinase type 1-interacting protein  LOC316561 
NM_134385 2.74138 prolactin-like protein C beta  Plpcbeta 
NM_138533 2.683087 F-spondin 2  LOC171569 
AY488087 2.585315 aristaless-related ALX3  mRNA Alx3 
NM_020100 2.483957 receptor (calcitonin) activity modifying protein 3  Ramp3 
NM_030862 2.419674 MARCKS-like protein  Mlp 
NM_053402 2.353076 wingless-type MMTV integration site family, member 4 Wnt4 
NM_022862 2.311108 Munc13-2 protein  Unc13h2 
NM_021688 2.22821 putative potassium channel TWIK  Kcnk1 
NM_013108 2.214405 adrenergic receptor, beta 3  Adrb3 
NM_133306 2.146935 oxidised low density lipoprotein (lectin-like) receptor 1  Olr1 
NM_053945 2.131525 Rim2 protein  Rim2 
NM_133562 2.082343 phosphatidylinositol (4,5) bisphosphate 5-phosphatase, A  Pib5pa 
XM_341442 2.005784 similar to FSHD region gene 1  LOC361156 
 
Genes Exhibiting Decreased Expression in Aged Relative to Normal 
Accessions Fold change Gene Name 
Gene 
Symbol 
NM_022221 18.41215724 neutrophil collagenease Mmp8 
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NM_031504 11.14082356 complement component 4a C4a 
NM_031766 10.5305542 carboxypeptidase Z Cpz 
NM_012598 10.41695742 lipoprotein lipase Lpl 
NM_012725 8.52940266 kallikrein B, plasma 1 Klk3 
NM_013104 8.129852891 insulin-like growth factor binding protein 6 Igfbp6 
NM_145682 8.111516679 filamin-interacting protein L-Filip Filip 
NM_172067 6.884874942 f-spondin Sponf 
NM_031327 6.392179933 cysteine rich protein 61 Cyr61 
XM_342661 6.288972334 similar to RIKEN cDNA B130055L09  
NM_012834 6.092287298 cartilage oligomeric matrix protein Comp 
NM_031327 5.503773498 cysteine rich protein 61 Cyr61 
M92340 5.22594573 interleukin 6 signal transducer Il6st 
NM_012999 4.766778356 Subtilisin - like endoprotease Pace4 
NM_022195 4.639052181 involucrin gene Ivl 
XM_343566 4.136514868 similar to TMEFF2  
NM_133527 4.092178205 folate receptor 1 (adult) Folr1 
XM_341561 3.923599813 similar to ARMET protein precursor   
NM_031337 3.898125126 sialyltransferase 9  Siat9 
NM_199502 3.820039377 Rincken CDNA  
NM_017244 3.819100593 cellular retinoic acid binding protein 2 Crabp2 
NM_022513 3.757624885 dopa/tyrosine sulfotransferase LOC64305 
NM_053896 3.745812365 aldehyde dehydrogenase family 1, subfamily A2 Aldh1a2 
NM_181085 3.697560604 lipoma HMGIC fusion partner LOC300286 
NM_134413 3.533039532 NAC-1 protein Nac-1 
M92916 3.396550034 Glucose-dependent insulinotropic peptide Gludins 
NM_012786 3.381219734 Cytochrom c oxidase subunit VIII-H  Cox8h 
NM_053492 3.194498258 transporter-like protein Ctl1 
NM_019258 3.093258301 cystatin 8 Cst8 
NM_057100 3.060279853 growth arrest specific 6 Gas6 
NM_012551 3.053079346 early growth response 1 Egr1 
XM_231692 3.042899218 v-raf murine sarcoma viral oncogene homolog B1 Braf 
NM_130744 2.92375756 stellate cell activation associated protein Staap 
NM_031315 2.91132139 cytosolic acyl-CoA thioesterase 1 Cte1 
NM_053594 2.895560158 protein tyrosine phosphatase, receptor type, R Ptprr 
NM_031509 2.794028707 glutathione S-transferase, alpha 1 Gsta1 
BC061739 2.767732092 similar to interleukin 17 receptor E isoform 1 LOC362417 
NM_175763 2.724292643 inhibin binding protein InhBP 
NM_012947 2.721995956 eukaryotic elongation factor-2 kinase Eef2k 
XM_226743 2.698081474 similar to neuronal apoptosis inhibitory protein  
NM_133284 2.688565816 progastricsin Pgc 
NM_012595 2.675605917 lactate dehydrogenase B Ldhb 
NM_031321 2.663514518 slit homolog 3 (Drosophila) Slit3 
NM_198784 2.641748408 alpha-2u globulin LOC362527 
XM_342774 2.623367942 cAMP responsive element binding protein-like 2  
NM_017094 2.618919911 growth hormone receptor Ghr 
NM_012608 2.612595059 membrane metallo endopeptidase Mme 
NM_053865 2.60918678 reticulon 1 Rtn1 
NM_022396 2.591562496 guanine nucleotide binding protein  Gng11 
NM_144755 2.56909102 kinase LOC246273 
NM_012886 2.42383804 tissue inhibitor of metalloproteinase 3 Timp3 
AF436847 2.420454854 complement component factor h Cfh 
NM_017330 2.399409953 cytolysin RATCYTA 
NM_031154 2.363893507 glutathione S-transferase, mu type 3 (Yb3) Gstm3 
NM_022847 2.361935379 progesterone receptor Pgr 
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NM_012969 2.348917063 insulin receptor substrate 1 Irs1 
U31203 2.343348617 noggin Nog 
NM_012688 2.330077263 cholecystokinin A receptor Cckar 
NM_031756 2.326138201 gamma-glutamyl carboxylase Ggcx 
NM_182816 2.323318292 transmembrane protein AMIGO2 Amigo2 
NM_022287 2.317539872 solute carrier family 26 ,member 1 Slc26a1 
XM_230861 2.306281162 similar to sulfatase FP  
NM_022198 2.284702838 putative chloride channel (Mm Clcn4-2) Clcn4-2 
NM_145774 2.261976757 Rab38, member of RAS oncogene family Rab38 
NM_170787 2.254906209 cytomatrix protein p110 CAST 
NM_021750 2.247839858 cysteine-sulfinate decarboxylase Csad 
NM_021774 2.247515633 fragile histidine triad protein Fhit 
XM_219273 2.243373249 similar to suppression of tumorigenicity 5  
NM_012595 2.2206714 lactate dehydrogenase B Ldhb 
NM_030873 2.219242157 profilin II Pfn2 
NM_031782 2.218298173 vesicular inhibitory amino acid transporter Viaat 
NM_031027 2.186409666 dihydropyrimidine dehydrogenase Dpyd 
NM_183327 2.182484943 gamma-aminobutyric acid  A receptor,  Gabrg2 
NM_031357 2.180900594 ceroid-lipofuscinosis, neuronal 2 Cln2 
NM_139194 2.177506417 Tumor necrosis factor receptor superfamily, member 6 Tnfrsf6 
NM_019190 2.169461334 membrane cofactor protein Mcp 
NM_031635 2.086687674 fucosyltransferase 2 Fut2 
NM_013042 2.058421684 trefoil factor 3 Tff3 
U20796 2.054655053 nuclear receptor subfamily 1, group D, member 2 Nr1d2 
NM_022936 2.04950956 cytosolic epoxide hydrolase Ephx2 
NM_031973 2.024602405 dipeptidylpeptidase 7 Dpp7 
NM_053736 2.024524547 caspase 11 Casp11 
AF260258 2.018291209 synaptojanin 2 binding protein Synj2bp 
NM_013082 2.000681384 syndecan 2 Sdc2 
 
 
 
Genes Exhibiting Increased Expression in Aged Relative to Normal 
Accessions Fold Change Gene Name Symbol 
AF110025 8.39708 solute carrier family 22 (organic cation transporter) Slc22al2 
NM_147205 14.16675337 sialyltransferase 1 Siat1 
NM_019280 12.36117798 gap junction membrane channel protein alpha 5 Gja5 
NM_053394 9.629100673 Kruppel-like factor 5 (intestinal) Klf5 
NM_031123 6.969684363 stanniocalcin 1 Stc1 
NM_178093 6.598956025 transcription factor MTSG1 Mtsg1 
NM_138533 6.089992872 F-spondin LOC171569 
NM_012696 5.904433228 T-kininogen Kng 
NM_022194 5.689746873 interleukin 1 receptor antagonist gene Il1rn 
M31155 5.165758654 prolactin-like protein B Prlpb 
AF311886 4.762383741 cytochrome P450-like protein Loc266761 
NM_022605 4.511140594 heparanase Hpse 
XM_226731 4.463675756 similar to RP105  
NM_053322 4.098994277 nuclear pore membrane glycoprotein 210 Pom210 
NM_020100 3.817596082 receptor (calcitonin) activity modifying protein 3 Ramp3 
NM_022297 3.76132761 dimethylarginine dimethylaminohydrolase 1 Ddah1 
NM_022935 3.634004178 amiloride binding protein 1 Abp1 
NM_139097 3.543705629 sodium channel beta 3 subunit Scnb3 
NM_138882 3.340577252 phosphatidylserine-specific phospholipase A1 Pspla1 
NM_057191 3.32792454 sarcomeric muscle protein Sarcosin 
 24
NM_133390 3.251234187 gonadotropin inducible ovarian transcription factor 2 Giot2 
NM_021762 3.23860944 translin Tsn 
XM_342925 3.215263728 similar to syncoilin  
NM_173293 3.205105064 olfactory receptor 78 Olfr78 
NM_053322 3.108771127 nuclear pore membrane glycoprotein 210 Pom210 
L36460 3.005095539 interleukin 9 Il9 
XM_235264 2.938917403 similar to atypical GATA protein TRPS1  
NM_053995 2.9124726 3-hydroxybutyrate dehydrogenase (heart, mitochondrial) Bdh 
XM_344233 2.894449469 similar to genomic screen homeobox protein 2  
NM_053567 2.890940194 formiminotransferase cyclodeaminase Ftcd 
XM_342877 2.694384942 similar to ApoE receptor-2  
CF107337 2.694021119 Trace amine receptor 8 Ta8 
NM_172047 2.646037775 
testosterone regulated apoptosis inducer and tumor 
suppressor Traits 
NM_181822 2.645697727 NK receptor 1c7 1C7 
NM_012548 2.632329164 endothelin 1 Edn1 
NM_031747 2.614717249 Calponin 1 Cnn1 
NM_021868 2.611135419 cortactin isoform B Cttnb 
NM_013194 2.539760999 myosin, heavy polypeptide 9 Myh9 
NM_032062 2.531236041 huntingtin-associated protein interacting protein (duo) Hapip 
NM_145788 2.474993438 TRAF family member-associated Nf-kappa B activator Tank 
NM_138511 2.471946567 cerebroglycan Gpc2 
U09229 2.426201787 cut (Drosophila)-like 1 Cutl1 
NM_024349 2.396971131 adenylate kinase 1 Ak1 
NM_030862 2.371534669 MARCKS-like protein Mlp 
NM_017180 2.360473563 T-cell death associated gene Tdag 
NM_017183 2.353826984 interleukin 8 receptor, beta Il8rb 
NM_134385 2.334932043 prolactin-like protein C beta Plpcbeta 
NM_013177 2.287094843 glutamate oxaloacetate transaminase 2 Got2 
NM_023021 2.286703856 
intermediate conductance calcium-activated potassium 
channel Kcnn4 
M24353 2.256595956 mannosidase 2, alpha 1 Man2a1 
XM_237258 2.254008207 similar to CocoaCrisp  
NM_053992 2.239360401 neuroligin 2 Nlgn2 
NM_053336 2.227507931 advanced glycosylation end product-specific receptor Ager 
NM_031240 2.22686027 testis specific protein 1 Tpx1 
NM_013036 2.197839903 somatostatin receptor 4 Sstr4 
NM_022686 2.1900343 Germinal histone H4 gene Hist4 
NM_017076 2.14387992 tumor-associated antigen 1 Taa1 
NM_024484 2.129784441 aminolevulinic acid synthase 1 Alas1 
NM_133534 2.120399439 Rbs11 protein Rbs11 
XM_236948 2.105379368 similar to taube nuss  
NM_053601 2.08965132 neuronatin Nnat 
NM_134412 2.053212752 PMF32 protein Pmf31 
 
 
